Application Nr Approved Date Route Status External Links
NDA212690 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xywav Is Indicated For The Treatment Of Cataplexy Or Excessive Daytime Sleepiness (Eds) In Patients 7 Years Of Age And Older With Narcolepsy. Xywav Is A Central Nervous System Depressant Indicated For The Treatment Of Cataplexy Or Excessive Daytime Sleepiness (Eds) In Patients 7 Years Of Age And Older With Narcolepsy ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 4 Total)

Comments